MAPT and Alzheimer disease: Considering that concomitant AD co-pathology in LBD patients is reflected in CSF biomarkers, including tau and Aβ2, our results are consistent with previous studies showing a strong influence of AD pathology on cognitive dysfunction in PD patients4,23,25,26.